As Kinder Morgan Del (KMI) Valuation Declined, Jrm Investment Counsel Has Decreased Position; Marathon Capital Management Maintains Position in Celgene (CELG)

April 24, 2018 - By Linda Rogers

Kinder Morgan, Inc. (NYSE:KMI) Logo

Jrm Investment Counsel Llc decreased its stake in Kinder Morgan Inc Del (KMI) by 30.05% based on its latest 2017Q4 regulatory filing with the SEC. Jrm Investment Counsel Llc sold 49,142 shares as the company’s stock declined 16.40% with the market. The institutional investor held 114,374 shares of the public utilities company at the end of 2017Q4, valued at $2.07M, down from 163,516 at the end of the previous reported quarter. Jrm Investment Counsel Llc who had been investing in Kinder Morgan Inc Del for a number of months, seems to be less bullish one the $35.81 billion market cap company. The stock decreased 1.28% or $0.21 during the last trading session, reaching $16.23. About 6.59M shares traded. Kinder Morgan, Inc. (NYSE:KMI) has declined 28.25% since April 24, 2017 and is downtrending. It has underperformed by 39.80% the S&P500.

Marathon Capital Management increased its stake in Celgene Corp (CELG) by 24.53% based on its latest 2017Q4 regulatory filing with the SEC. Marathon Capital Management bought 4,195 shares as the company’s stock declined 19.30% with the market. The institutional investor held 21,295 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $2.22 million, up from 17,100 at the end of the previous reported quarter. Marathon Capital Management who had been investing in Celgene Corp for a number of months, seems to be bullish on the $67.06 billion market cap company. The stock decreased 0.36% or $0.32 during the last trading session, reaching $89.16. About 2.69M shares traded. Celgene Corporation (NASDAQ:CELG) has declined 31.28% since April 24, 2017 and is downtrending. It has underperformed by 42.83% the S&P500.

Since February 8, 2018, it had 1 insider buy, and 3 sales for $3.58 million activity. LOUGHLIN JAMES J sold $851,093 worth of stock. The insider Alles Mark J bought 3,260 shares worth $299,594. $1.77M worth of Celgene Corporation (NASDAQ:CELG) shares were sold by KAPLAN GILLA.

Marathon Capital Management, which manages about $255.99M US Long portfolio, decreased its stake in General Electric Company (NYSE:GE) by 59,218 shares to 53,108 shares, valued at $926,000 in 2017Q4, according to the filing. It also reduced its holding in Dowdupont Inc by 5,526 shares in the quarter, leaving it with 45,754 shares, and cut its stake in Silver Spring Networ (NYSE:SSNI).

Investors sentiment decreased to 0.83 in 2017 Q4. Its down 0.34, from 1.17 in 2017Q3. It turned negative, as 156 investors sold CELG shares while 478 reduced holdings. 118 funds opened positions while 411 raised stakes. 561.38 million shares or 7.06% less from 603.99 million shares in 2017Q3 were reported. Glenview National Bank Dept stated it has 0.75% of its portfolio in Celgene Corporation (NASDAQ:CELG). Johnson Inv Counsel owns 92,552 shares. Cypress Cap Mgmt Ltd Llc (Wy) holds 48,891 shares or 5.78% of its portfolio. Plante Moran Financial Advisors Ltd has invested 0.08% in Celgene Corporation (NASDAQ:CELG). Valley National Advisers Inc has 0.29% invested in Celgene Corporation (NASDAQ:CELG). Pictet Natl Bank holds 1.36% or 44,372 shares in its portfolio. Allen Investment Mngmt Limited Liability Corporation invested in 0.02% or 4,154 shares. Kentucky-based Regent Limited Liability has invested 1.71% in Celgene Corporation (NASDAQ:CELG). Fdx Advsrs Incorporated stated it has 0.07% of its portfolio in Celgene Corporation (NASDAQ:CELG). North Carolina-based Piedmont Investment Advisors Ltd Liability Co has invested 0.35% in Celgene Corporation (NASDAQ:CELG). Redmile Grp Lc reported 2.97% of its portfolio in Celgene Corporation (NASDAQ:CELG). Forte Cap Ltd Liability Company Adv holds 0.1% or 3,250 shares. Clear Harbor Asset Mgmt Ltd Liability stated it has 3,326 shares or 0.07% of all its holdings. City Hldgs Com has invested 0.06% in Celgene Corporation (NASDAQ:CELG). Twin Tree Mgmt LP reported 0.05% stake.

Among 34 analysts covering Celgene Corporation (NASDAQ:CELG), 19 have Buy rating, 1 Sell and 14 Hold. Therefore 56% are positive. Celgene Corporation had 142 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Thursday, September 29 by Citigroup. The rating was upgraded by Argus Research to “Buy” on Monday, July 31. SunTrust downgraded the stock to “Hold” rating in Wednesday, February 28 report. The rating was maintained by Oppenheimer with “Buy” on Wednesday, June 14. The firm has “Buy” rating by RBC Capital Markets given on Wednesday, October 4. The stock of Celgene Corporation (NASDAQ:CELG) earned “Outperform” rating by BMO Capital Markets on Tuesday, October 17. Morgan Stanley maintained Celgene Corporation (NASDAQ:CELG) on Friday, April 13 with “Equal-Weight” rating. The stock has “Buy” rating by Stifel Nicolaus on Wednesday, February 28. The rating was initiated by Suntrust Robinson with “Buy” on Thursday, January 7. The firm has “Buy” rating by Jefferies given on Monday, July 10.

Among 25 analysts covering Kinder Morgan (NYSE:KMI), 17 have Buy rating, 0 Sell and 8 Hold. Therefore 68% are positive. Kinder Morgan had 84 analyst reports since July 30, 2015 according to SRatingsIntel. Goldman Sachs downgraded the shares of KMI in report on Tuesday, October 17 to “Hold” rating. Jefferies maintained it with “Hold” rating and $2300 target in Thursday, June 22 report. The rating was downgraded by Credit Suisse to “Neutral” on Thursday, October 22. SunTrust maintained it with “Buy” rating and $2100 target in Wednesday, April 18 report. RBC Capital Markets maintained it with “Outperform” rating and $36 target in Thursday, October 22 report. The firm has “Overweight” rating by JP Morgan given on Monday, February 12. The firm has “Overweight” rating by Morgan Stanley given on Friday, February 9. The company was maintained on Tuesday, June 20 by BMO Capital Markets. Jefferies maintained the shares of KMI in report on Monday, April 16 with “Hold” rating. RBC Capital Markets maintained Kinder Morgan, Inc. (NYSE:KMI) on Thursday, December 3 with “Outperform” rating.

Kinder Morgan, Inc. (NYSE:KMI) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: